These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4095213)

  • 1. [Monitored supportive treatment of chronic schizophrenia with delayed-action clopenthixol].
    Welbel L; Nurowska K; Szukalski B; Lipska B
    Psychiatr Pol; 1985; 19(2):109-14. PubMed ID: 4095213
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical experience with Cis-(Z-)Clopenthixol-Decanoate (Sordinol-Depot) (author's transl)].
    Zmorski T; Unterrassner R
    Schweiz Rundsch Med Prax; 1979 Nov; 68(48):1605-9. PubMed ID: 538008
    [No Abstract]   [Full Text] [Related]  

  • 3. [cis(Z)-Clopenthixol decanoate--a new depot neuroleptic].
    Sieberns S; Spechtmeyer H
    Int Pharmacopsychiatry; 1982; 17(3):170-84. PubMed ID: 7141812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance treatment of chronic schizophrenic patients. A study with the long-acting thioxanthene derivative, cis(Z)-clopenthixol decanoate-sordinol depot.
    Dom R; De Mesmaecker L; van den Broucke M; van Hest T; Baro F
    Acta Psychiatr Scand; 1978 Apr; 57(4):299-304. PubMed ID: 352094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind clinical investigation of cis(Z)-clopenthixol and clopenthixol in chronic schizophrenic patients.
    Heikkilä L; Karsten D; Valli K
    Acta Psychiatr Scand Suppl; 1981; 294():25-9. PubMed ID: 7041516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open clinical study of cis(Z)-clopenthixol.
    Sechter D; Caillard V; Cuche H; Deniker P
    Acta Psychiatr Scand Suppl; 1981; 294():20-4. PubMed ID: 6951393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clopenthixol-decanoate in ambulatory psychiatric (author's transl)].
    Hochenegg L
    Schweiz Rundsch Med Prax; 1978 Jul; 67(28):1048-52. PubMed ID: 674084
    [No Abstract]   [Full Text] [Related]  

  • 8. Clopenthixol decanoate and perphenazine enanthate in schizophrenic patients. A double-blind Nordic multicentre trial.
    Ahlfors UG; Dencker SJ; Gravem A; Remvig J
    Acta Psychiatr Scand Suppl; 1980; 279():77-91. PubMed ID: 6996426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A specific method for assay of drug levels in serum of patients treated with clopenthixol decanoate injections.
    Overø KF
    Acta Psychiatr Scand Suppl; 1980; 279():92-103. PubMed ID: 6931474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Maintenance therapy using clopenthixol decanoate in schizophrenic patients].
    Kabes J; Balon R; Papezová H
    Cesk Psychiatr; 1986 Aug; 82(3-4):189-94. PubMed ID: 3769007
    [No Abstract]   [Full Text] [Related]  

  • 11. [A 1-year experience with the administration of clopenthixol decanoate in schizophrenic psychoses].
    Svestka J; Náhunek K; Cesková E; Rysánek R
    Cesk Psychiatr; 1984 Jun; 80(3):146-54. PubMed ID: 6148152
    [No Abstract]   [Full Text] [Related]  

  • 12. [A new injectable delayed-action neuroleptic with sedative and antipsychotic action: cis-(Z)-clopenthixol decanoate. Clinical trials].
    Lambert PA; Chabannes JP
    Encephale; 1984; 10(2):83-91. PubMed ID: 6381033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 5-year follow-up study of chronic schizophrenics treated with clopenthixol decanoate.
    Carney MW
    Pharmatherapeutica; 1984; 4(1):57-63. PubMed ID: 6150493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clopenthixol decanoate in schizophrenia.
    Carney MW; Rutherford P
    Curr Med Res Opin; 1981; 7(4):205-11. PubMed ID: 6112116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cis(Z)-clopenthixol and haloperidol in chronic schizophrenic patients--a double-blind clinical multicentre investigation.
    Heikkilä L; Laitinen J; Vartiainen H
    Acta Psychiatr Scand Suppl; 1981; 294():30-8. PubMed ID: 7041517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Findings with cis-Z-clopenthixol in the treatment of acute mania and schizophrenia.
    König P; Seifert T; Eberhardt G
    Pharmacopsychiatry; 1986 Nov; 19(6):424-8. PubMed ID: 3797470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment of chronic schizophrenics with clopenthixol decanoate.
    Borsetti G; Rocco P; Spilimbergo PG; Giavedoni A; Frangiamone L; Beccaceci A; Judice A; Cisternino M; Volterra V
    Pharmatherapeutica; 1984; 4(1):53-6. PubMed ID: 6150492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clopenthixol decanoate in the treatment of chronic schizophrenic in-patients.
    Viswanathan R; Rajhkowa S
    Pharmatherapeutica; 1982; 3(2):93-9. PubMed ID: 7100227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The positive and negative symptoms of schizophrenia: patterns of response to depot neuroleptic treatment.
    Martyns-Yellowe IS
    West Afr J Med; 1994; 13(4):200-3. PubMed ID: 7756183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. IV. Serum levels and clinical outcome.
    Dencker SJ; Malm U; Jørgensen A; Overø KF
    Acta Psychiatr Scand Suppl; 1980; 279():55-63. PubMed ID: 6931473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.